AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
ImmuPharma (LON:IMM) Sees 27.6% Surge – What’s Driving the Momentum?
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma's (IMM) shares surged by 27.6% during recent trading.,Stock reached a high of GBX 3.60 before closing at GBX 3.35.,Market capitalization stands at £13.95 million, signaling increased investor attention.,ImmuPharma plc (LON:IMM),...
ImmuPharma (LON:IMM) Rises 27.6% Amid Renewed Market Interest
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma shares climbed 27.6% during recent trading, reaching GBX 3.60 at their peak.,Trading volume declined 61% compared to the average daily activity, with 8,992,934 shares traded.,The company focuses on developing peptide-based thera...
ImmuPharma (LON:IMM) Climbs 27.6% Amid Renewed Focus on Therapeutic Innovations
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma shares surged 27.6% during recent trading, reaching an intraday high of GBX 3.60.,Trading volume saw a 61% decline from the average, with 8,992,934 shares changing hands.,The company’s lead program, P140 (Lupuzor™), targets Lupu...
ImmuPharma (LON:IMM) Sees 27.6% Rise in Stock Price
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma (IMM) stock price surged 27.6% on Saturday.,Trading volume reached 8,992,934 shares, marking a 61% decrease from the average.,The company specializes in peptide-based therapeutics for autoimmune diseases.,ImmuPharma plc (LON:IMM...
ImmuPharma (LON:IMM) Experiences Notable Stock Surge of 27.6%
January 20, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma (IMM) shares surged by 27.6% during Saturday's trading session.,Stock peaked at GBX 3.60, closing at GBX 3.35, marking a significant increase.,Trading volume of 8,992,934 shares was notably lower than average daily volume.,ImmuP...
Futura Medical's Stock Movement and Healthcare Innovations
January 17, 2025 09:12 PM AEDT| By Team Kalkine MediaHeadlines,Futura Medical's Momentum Shifts Below Moving Average,Exploring Futura's Pharmaceutical Innovations,Understanding Futura's Strategic Product Portfolio,Futura Medical plc,,(LON:FUM),a prominent name in the pharmaceutical industry, has recent...
Avacta Therapeutics Announces Promising Tumor Shrinkage Data in Salivary Gland Cancer for AVA6000
January 16, 2025 06:27 PM AEDT| By Team Kalkine MediaHighlights,Encouraging Results in Salivary Gland Cancer:,New Phase 1a data shows meaningful tumor shrinkage in patients with salivary gland cancer (SGC), a rare and challenging disease with no standard metastatic therapy.,Advancing into Phase 1b Tria...
Genus Expects FY25 Half-Year Performance to Exceed Expectations
January 15, 2025 07:07 PM AEDT| By Team Kalkine MediaHighlights:,Adjusted Profit Before Tax Expected to Exceed £35 Million,Strong Performance Across ABS and PIC Divisions,Progress in PRRS1 Resistant Pig Programme Regulatory Approval,Genus (LSE:GNS), a global leader in animal genetics, expects to report...
Biotech Growth Trust: Insights into Recent Insider Activity and Strategic Focus
January 15, 2025 03:30 PM AEDT| By Team Kalkine MediaHeadlines,Nicola Shepherd, an insider at The Biotech Growth Trust PLC, made a notable share purchase.,The Biotech Growth Trust PLC focuses on investments in the biotechnology sector.,The company's financial metrics and performance have drawn attentio...
Gym Group Faces Key Market Challenges Amid Insider Confidence
January 15, 2025 06:29 AM AEDT| By Team Kalkine MediaHeadlines,The Gym Group's stock crosses below key moving averages.,Insider activity shows confidence in the company's performance.,Key financial metrics reflect the company's ongoing challenges.,The Gym Group,(LON:GYM),recently saw its stock drop bel...
Trellus Health Partners with Johnson & Johnson for Inflammatory Bowel Disease Pilot Program
January 14, 2025 06:54 PM AEDT| By Team Kalkine MediaHighlights:,Strategic Partnership,: Trellus Health will integrate its Trellus Elevate™ program into a Patient Support Program (PSP) for eligible patients prescribed a Johnson & Johnson therapy for IBD.,Financial Terms,: Trellus Health will receive an...
Oxford Nanopore Technologies Sees Strong Growth Amidst Innovation in Biotechnology
January 13, 2025 09:37 PM AEDT| By Team Kalkine MediaHeadlines,Oxford Nanopore Gains Momentum in Trading,Innovative Technologies Elevate Oxford Nanopore,Strategic Advancements Spark Renewed Interest,Oxford Nanopore Technologies plc,(LON:ONT),witnessed a notable rise in trading activity recently, showca...
ImmuPharma Gains Momentum with Promising Lupuzor Developments
January 13, 2025 09:35 PM AEDT| By Team Kalkine MediaHeadlines,ImmuPharma's Performance Gains Momentum,Focus on Innovative Therapeutics,Lupuzor: A Promising Development,ImmuPharma plc (LON:IMM),recently witnessed a notable increase in its stock price during Saturday's trading session. The company's sha...
GSK to Acquire IDRx for $1.15 Billion, Strengthening Precision Therapeutics Portfolio
January 13, 2025 06:33 PM AEDT| By Team Kalkine MediaHighlights,Strategic Acquisition,: GSK will pay $1 billion upfront, with an additional $150 million tied to regulatory approval milestones.,Breakthrough Therapy Potential,: IDRX-42 shows promising efficacy in addressing primary and secondary KIT muta...
Avacta Therapeutics Appoints Brian Hahn as Chief Financial Officer
January 13, 2025 06:29 PM AEDT| By Team Kalkine MediaHighlights,Brian Hahn's Extensive Industry Experience,: Over 25 years in senior financial roles within the biopharmaceutical sector, including a pivotal tenure at GlycoMimetics, Inc.,Proven Expertise in Strategic Financial Leadership,: Successfully l...
ImmuPharma's Stock Surge Reflects Growing Investor Interest
January 13, 2025 04:51 PM AEDT| By Team Kalkine MediaHeadlines,ImmuPharma has seen a notable increase in trading activity, reflecting heightened interest in the company.,The stock demonstrated impressive upward movement in recent sessions.,The pharmaceutical company's developments have drawn significan...
ImmuPharma plc (LON:IMM) Sees Notable Share Price Surge Amid Trading Activity
January 13, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,ImmuPharma shares rose by 4.9% during mid-day trading.,Trading volume surged, with over 109 million shares exchanged.,The company's P/E ratio stands at a negative value, indicating challenges.,ImmuPharma plc (LON:IMM) saw a 4.9% increase i...
Oxford Nanopore Technologies (LON:ONT) Sees 20.4% Surge in Stock Price
January 13, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Oxford Nanopore Technologies (ONT) stock rose 20.4% on Monday.,1 million shares exchanged hands, showing significant trading volume.,Market cap stands at £1.49 billion, with strong liquidity ratios.,Shares of Oxford Nanopore Technologies p...
ImmuPharma's Surge: A Closer Look at Recent Performance
January 13, 2025 06:50 AM AEDT| By Team Kalkine MediaHeadlines,ImmuPharma's Stock Soars,Significant Trading Activity and Movement,The Company's Role in Biopharmaceuticals and Autoimmune Treatments,ImmuPharma plc,(LON:IMM),has recently experienced a notable surge in stock price, attracting considerable...
Verici Dx Innovates Kidney Transplant Testing Amid Stock Volatility
January 13, 2025 06:46 AM AEDT| By Team Kalkine MediaHeadlines,Verici Dx Faces Decline in Stock Price Amid Market Activity,Company’s Focus on Kidney Transplant Testing Technology,Key Performance Indicators and Future Prospects for Verici Dx,Verici Dx, listed under ticker,LON:VRCI,, has seen a decrease...
AI on the Rise: A Look at Top AI Companies and Their Stocks